To cite this paper use one of the standards below:
Modulation of endocannabinoid system contributes to analgesia, highlighting its promising role on the suppression of neuropathic pain. Recently, arachidonylamides have been identified as cannabinoid receptor ligands, which suggests their potential role on the analgesic activity displayed by dipyrone. Compounds 6-11 were designed by molecular hybridization of non-steroidal anti-inflammatory drugs (2-4) with the major metabolites of dipyrone. All substances were obtained in good yields (50-80%) and presented good drug-like properties, such as aqueous solubility (10-70 μM), lipophilicity (log D7.4 ranging from 1-3), metabolic and chemical stability against pH (2 and 7.4). Compounds 6-11 showed medium to high permeability by PAMPA assay (GIT and BBB). The compounds presented inverse agonist activity for CB2 receptors in vitro (EC50 = 0.36 µM; Emax = 63%). Compound 11 was selected to demonstrate their analgesic activity in the formalin test and the results indicated activity in the inflammatory phase associated with an pain condition.
With nearly 200,000 papers published, Galoá empowers scholars to share and discover cutting-edge research through our streamlined and accessible academic publishing platform.
Learn more about our products:
This proceedings is identified by a DOI , for use in citations or bibliographic references. Attention: this is not a DOI for the paper and as such cannot be used in Lattes to identify a particular work.
Check the link "How to cite" in the paper's page, to see how to properly cite the paper